Login / Signup

Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies.

Jinqi HuangStepanov AlexeyJian LiTerri JonesGeramie GrandeLacey DouthitJun XieDanna ChenXiaolei WuMaschan MichaelChangchun XiaoJiangning ZhaoXuehua XieJia XieXiao Lei ChenGuo FuGabibov AlexanderChi-Meng Tzeng
Published in: Leukemia (2019)
Keyphrases
  • cancer therapy
  • monoclonal antibody